140 related articles for article (PubMed ID: 23047938)
1. Role of fenofibrate in restoring angiogenesis in diabetic and control hind limb ischemic rats.
Salehi E; Khazaei M; Rashidi B
Gen Physiol Biophys; 2012 Sep; 31(3):255-60. PubMed ID: 23047938
[TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
3. Restoration of angiogenesis by enalapril in diabetic hindlimb ischemic rats.
Fallahzadeh AR; Khazaei M; Sharifi MR
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Jun; 155(2):137-42. PubMed ID: 21804622
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate, a peroxisome proliferator-activated receptor alpha, improves myocardial capillary density in diabetic rats.
Salehi E; Khazaei M
J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S9-12. PubMed ID: 22768449
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate enhances neovascularization in a murine ischemic hindlimb model.
Katayama A; Yamamoto Y; Tanaka K; Matsubara K; Sugitani M; Fujihara S; Harada S; Kaetsu Y; Yoshida A; Hisatome I
J Cardiovasc Pharmacol; 2009 Nov; 54(5):399-404. PubMed ID: 19701095
[TBL] [Abstract][Full Text] [Related]
6. Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model.
Yang HB; Liu HM; Yan JC; Lu ZY
J Cardiovasc Pharmacol; 2018 Jun; 71(6):367-374. PubMed ID: 29642134
[TBL] [Abstract][Full Text] [Related]
7. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
9. Role of simvastatin and/or antioxidant vitamins in therapeutic angiogenesis in experimental diabetic hindlimb ischemia: effects on capillary density, angiogenesis markers, and oxidative stress.
El-Azab MF; Hazem RM; Moustafa YM
Eur J Pharmacol; 2012 Sep; 690(1-3):31-41. PubMed ID: 22705060
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
11. Limbs' postischemic revascularization is not improved by losartan treatment in diabetic rats.
Fallahzadeh A; Khazaei M
Endocr Regul; 2014 Jan; 48(1):9-15. PubMed ID: 24524371
[TBL] [Abstract][Full Text] [Related]
12. Kinin receptor agonism restores hindlimb postischemic neovascularization capacity in diabetic mice.
Desposito D; Potier L; Chollet C; Gobeil F; Roussel R; Alhenc-Gelas F; Bouby N; Waeckel L
J Pharmacol Exp Ther; 2015 Feb; 352(2):218-26. PubMed ID: 25398240
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
14. Role of peroxisome proliferator-activated receptor β agonist on angiogenesis in hindlimb ischemic diabetic rats.
Khazaei M; Salehi E; Rashidi B; Javanmard SH; Fallahzadeh AR
J Diabetes Complications; 2012; 26(2):137-40. PubMed ID: 22464549
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ.
Biscetti F; Pecorini G; Arena V; Stigliano E; Angelini F; Ghirlanda G; Ferraccioli G; Flex A
Mol Cell Endocrinol; 2013 Dec; 381(1-2):80-7. PubMed ID: 23891623
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
17. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
19. The effect of vascular endothelial growth factor on angiogenesis: an experimental study.
Becit N; Ceviz M; Koçak H; Yekeler I; Unlü Y; Celenk C; Akin Y
Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):310-6. PubMed ID: 11563889
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.
Hsieh MJ; Liu HT; Wang CN; Huang HY; Lin Y; Ko YS; Wang JS; Chang VH; Pang JS
J Mol Med (Berl); 2017 Mar; 95(3):323-333. PubMed ID: 27847966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
